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Introduction
Malignant distal bile duct obstruction is caused by carcinoma
of the pancreas, distal common bile duct, ampulla of Vater,
gallbladder or duodenum. Unfortunately, most patients are
elderly and/or have an advanced stage of disease at the time of
diagnosis, and are unsuitable for curative resection.
Palliative treatment is usually performed to relieve the
jaundice. Biliary-enteric surgical bypass has been the treat-
ment of choice for palliation of obstructive jaundice for many
years. The introduction of a minimally invasive endoscopic
stenting technique by Soehendra and Reynders-Frederix has
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provided a new option for clinicians, and this has become a
very popular procedure in the management of obstructive
jaundice.1 The choice between surgery and endoscopic drain-
age is a matter of personal preference and availability of alter-
native techniques. Comparative studies from Western coun-
tries have shown a similar efficacy between endoscopic drain-
age and surgical treatment. However, there are no data to
support these findings in developing countries, where cost-
effectiveness has to be considered. This study aimed to com-
pare the clinical outcomes, complications, survival time and
cost utility of endoscopic plastic stent drainage and surgical
drainage.
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OBJECTIVE: Palliative treatment of obstructive jaundice from advanced tumour of the distal bile duct is
controversial. The aim of this study was to compare the clinical outcomes and costs between endoscopic stent
insertion and surgery.
METHODS: The clinical data for 116 patients treated with either endoscopic plastic stenting (65 patients) or
surgical bypass (51 patients) were reviewed and analysed.
RESULTS: No significant difference was found between the two groups in terms of the length of hospital stay,
survival time, cost, effectiveness, and early complications. However, late complications were significantly more
common in the stenting group (p = 0.007). Jaundice recurred in 15 stented patients at a median time of 3 months
due to stent blockage, and one surgical patient had recurrent jaundice from anastomosis stricture. Late gastric
outlet obstruction occurred in one of 36 surgical patients who did not undergo prophylactic gastroenterostomy
and one of 65 stented patients developed this complication.
CONCLUSION: Both techniques are equally effective in biliary drainage, but stenting has a higher rate of
recurrent jaundice. We recommend surgery for patients with low surgical risks and endoscopic stent in those with
a short life expectancy or those unfit for surgery. [Asian J Surg 2005;28(4):262–5]
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Patients and methods
The medical records of 116 patients with a clinical diagnosis
of primary malignant obstruction of the distal bile duct who
were palliatively treated at Songklanagarind Hospital between
January 1992 and December 2003 with endoscopic plastic
stent drainage (straight double-flapped polyethylene, 10 Fr)
or biliary-enteric surgical bypass were reviewed. Data were
obtained from admission charts, follow-up clinical notes and
the population database of the Ministry of the Interior (for
patients who were lost to follow-up).
Selection of either endoscopic drainage or surgery was at
the discretion of the attending physician. The type of surgical
drainage procedure was determined by the operative find-
ings. Endoscopic stent drainage was performed as described
elsewhere.2 The diagnosis of malignancy was made by histopa-
thology or the clinical course of the patients when histopatho-
logical diagnosis was not available.
Outcome measures were defined as follows: effectiveness
of biliary drainage was the dropping of serum bilirubin to less
than 50% of the initial value; hospital stay was the number of
days in hospital from admission to first discharge; survival
time was the time from the procedure until the death of the
patient; complications were divided into two groups, early
(during the time the patient remained in the hospital) and
late (after discharge); mortality refers to deaths that were
procedure-related or which occurred within 30 days from the
time of the procedure; cost refers to hospital billing (initial
cost refers to the billing for the first admission, while total cost
refers to the total expense incurred from the first admission
until death).
Results are reported as mean ± standard error of the mean.
The 95% confidence interval (CI) was also calculated. A p value
of less than 0.05 was considered to be significant. The prob-
ability of survival was estimated using the Kaplan-Meier
method.
Results
Of the 116 patients, there were 68 males and 48 females, with
a mean age of 61.1 ± 1.2 years (range, 37–85 years). Tumours
were located in the pancreas (67), distal common bile duct
(39), ampulla of Vater (6), gallbladder (3) and duodenum (1).
Sixty-five patients were treated with endoscopic stent drainage
and 51 with a surgical bypass. The surgical procedures per-
formed in the surgical group were choledochojejunostomy in
31 patients, cholecystojejunostomy in 16 and choledocho-
duodenostomy in four.
Table 1 shows the characteristics of the patients prior to
treatment. There was no notable difference in age, gender,
initial total bilirubin, alkaline phosphatase and albumin levels
between the two groups. The clinical outcomes are shown in
Table 2. The surgical group seems to have had a longer hospital
stay and greater effectiveness of biliary drainage, but a shorter
Table 1. Patient characteristics
Stent (n = 65) Surgery (n = 51) p
Male/female 33/32 35/16 0.25
Mean age (yr) 60.9 ± 2.2 61.4 ± 2.0 0.86
Mean total bilirubin (mg%) 17.9 ± 1.9 15.7 ± 2.1 0.78
Mean alkaline phosphatase (U/L) 550.2 ± 70.5 546.6 ± 54.9 0.10
Mean albumin (g%) 003.4 ± 0.01 03.6 ± 0.1 0.73
Table 2. Clinical outcomes
Stent Surgery Difference (95% CI) p
Mean hospital stay (d) 26.3 ± 3.0 26.9 ± 1.4 –0.6 (–7.2 to 6.0) 0.86
Mean survival time (d) 191.9 ± 26.4 182.5 ± 26.9 00–9.4 (–64.8 to 83.0) 0.80
Mean initial cost (Thai baht) 048,269 ± 11,100 40,710 ± 3,995 0000–7,559 (–16,140 to 31,258) 0.59
Mean total cost (Thai baht) 100,094 ± 14,369 68,200 ± 7,172 031,894 (–122 to 63,910) 0.44
Effectiveness (%) 94.4 96.9 0–0.02 (–0.12 to 0.08) 0.93
Early complications (%) 10.8 13.7 –0.03 (–0.1 to 0.09) 0.62
Late complications (%) 24.6 05.9 00.2 (0.07 to 0.3) 0.007
CI = confidence interval.
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mean survival time and lower overall expense than the stenting
group, but the differences were not significant.
The details of complications and mortalities are shown in
Table 3. Early complications occurred in seven stented pa-
tients and seven surgical patients. Recurrent jaundice from
stent blockage was the most common late complication in
patients treated by the endoscopic method (22 blockages in
15 patients), with a median patency time of 3 months (range,
1–9 months). There were only three late complications in the
surgical group, which was a significantly lower rate than in the
stent group (p = 0.007).
Gastrojejunostomy during biliary-enteric bypass was per-
formed in 15 patients as a prophylactic measure against duo-
denal obstruction. One patient in the surgical group who had
not undergone gastrojejunostomy developed symptoms of
duodenal obstruction due to tumour invasion and required
gastrojejunostomy to relieve the symptoms. One of the pa-
tients treated with stent insertion developed duodenal ob-
struction during the follow-up period. The Figure shows the
survival curves for the two groups; there was no significant
difference.
Discussion
Most patients who are diagnosed with obstructive jaundice
due to malignant obstruction are not candidates for curative
surgical resection. Palliation by endoscopic stent drainage,
surgical bypass and percutaneous drainage are the main treat-
ment options available to the physician dealing with these
patients. The selection of treatment is influenced by the avail-
ability of the options and local expertise.3–5
Few randomized trials comparing endoscopic stenting
and surgical bypass have been reported. One early study by
Shepherd et al showed the same survival rate, but the stenting
group had shorter hospital stays with a higher readmission
rate.6 Andersen et al found the same.7 Smith et al confirmed
this, but also noted that surgical treatment resulted in a higher
rate of early complications, while stenting led to more recur-
rent jaundice.8 In our study, there was no significant difference
in early complications between the two methods of treatment.
However, since this was not a randomized study, one must
note the possibility of selection bias in that lower-surgical-risk
patients might have been treated using surgery while those at
higher surgical risk or a more advanced stage of disease were
offered endoscopic stenting. There was no difference between
the groups in the efficacy of biliary drainage, length of hospital
stay or survival rates. The stenting group had more late com-
plications than the surgical group due to the problem of stent
Table 3. Complications and causes of mortality
Stent (n = 65) Surgery (n = 51)
Early complications Cholangitis (5) Wound infection (2)
Stent migration (1) Anastomosis leakage (1)
Duodenal perforation (1) Intra-abdominal collection (1)
Delayed gastric emptying (1)
Postoperative pneumonia (1)
Postoperative cerebrovascular accident (1)
Late complications Stent blockage (15) (total 22 times) Anastomosis stricture (1)
Gastric outlet obstruction (1) Adhesion band gut obstruction (1)
Gastric outlet obstruction (1)
Mortality End-stage liver failure (2) Postoperative pneumonia (1)
Postoperative cerebrovascular accident (1)
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Figure. Survival curves in the surgery and stent groups are not
significantly different.
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blockage. Western studies found that surgical treatment
had higher initial and total hospital costs than endoscopic
stenting.9,10 Our study showed a slightly higher initial cost
and total cost for the endoscopic stent than for surgery, but
no statistical significance was detected.
A review by Wattanapa and Williamson found that 17% of
patients who underwent biliary bypass alone eventually de-
veloped a duodenal obstruction at a mean of 8.6 months la-
ter and required subsequent gastric bypass.11 Lillemore et al
randomized unresectable periampullary cancer patients and
showed that prophylactic gastrojejunostomy significantly
decreased the incidence of late gastric outlet obstruction (0/44
versus 8/43 who did not have the procedure).12 The median
time between initial exploration and therapeutic intervention
was 2 months. They suggested that gastroenterostomy be
undertaken at the time of the initial biliary bypass, as this
approach did not increase the mortality rate and the substan-
tial risk of mortality pertaining to a subsequent operation
could be avoided. Our series, however, showed that only
two of 101 patients (2%) who did not have a prophylactic gas-
troenterostomy later developed duodenal obstruction. This
difference might be because patients were diagnosed at a more
advanced stage in our series, as judged from the shorter sur-
vival time in this study than those reported by Wattanapa and
Williamson11 and Lillemore et al.12
Stent blockage was a major problem, occurring in 23% of
the patients in this study. The median patency time of 3
months with a range of 1–9 months is similar to those found
in other reports.6–10 The stent was changed only in the event of
recurrent jaundice or cholangitis in the cases in this study,
while others reported that the stent was routinely changed
every 3–6 months.13,14 The effect of these different approaches
in terms of cost-effectiveness, however, is not clear. A self-
expandable metallic stent, with a larger diameter compared
with a plastic stent when fully expanded, may decrease the
incidence of stent blockage. There have been a few randomized
trials showing more benefit from metallic than plastic stents
in reducing this problem.15–17 The major drawback of metallic
stents is their high cost, and another study indicates that
metallic stents are cost-effective only in patients who survive
for longer than 6 months.14
In conclusion, endoscopic stenting and surgical bypass are
equal in terms of effectiveness in biliary drainage. However,
the surgical approach seems to result in less recurrent jaundice
than the stent approach. We recommend surgery for patients
at low surgical risk, and an endoscopic stent for those with a
short life expectancy or who are unfit for surgery in a setting
such as our country, where reasonable cost-effectiveness must
be considered.
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